Reuters logo
BRIEF-Arena Pharmaceuticals, Eisai amend marketing and supply agreement for BELVIQ
January 4, 2017 / 9:26 PM / 9 months ago

BRIEF-Arena Pharmaceuticals, Eisai amend marketing and supply agreement for BELVIQ

Jan 4 (Reuters) - Arena Pharmaceuticals Inc

* Arena Pharmaceuticals and Eisai amend marketing and supply agreement for BELVIQ globally

* Arena Pharmaceuticals Inc - financial terms of revised agreement are expected to provide arena with $23 million of cash payments

* Arena Pharma-financial terms of revised deal expected to provide co with over $80 million of potential cost relief on current lorcaserin development obligations

* Arena Pharmaceuticals Inc - will continue to be eligible to receive royalty payments on net sales of Belviq Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below